Hanmi R&D creates a better future for humanity.

Overview

We focus on research areas with high unmet medical needs such as obesity/metabolism, oncology, and rare diseases.

Hanmi Pharmaceutical is a R&D-centric pharmaceutical company that focuses on developing new drugs for a better life for humanity. Hanmi Pharmaceutical is establishing and executing R&D strategies to create powerful, sustainable, and unprecedented innovations focusing on obesity/metabolism, oncology, and rare diseases with high unmet medical needs. Our current main pipeline includes long-acting new bio drugs and dual antibodies based on 'targeted protein control' and Hanmi's unique platform technology, 'LAPSCOVERY.' We also focus on developing FDCs and INDs to improve patient's quality of life. Hanmi Pharmaceutical is discovering new modalities such as 'ADC(antibody-drug conjugate), ' 'Cell/Gene Therapy,' 'mRNA-based Therapy,' and 'TPD(targeted protein degrader)' as next-generation technologies.

Primary Focus
Exploratory Research

R&D Network

We provide an optimal research environment through an organic R&D network with each center so that research-stage candidates can rapidly develop and reach the commercialization stage.

Hanmi R&D Center
- LocationDongtan, Gyeonggi-do, South Korea
- a field of studyNew drugs based on our technology and new modalities / New drugs in obesity/metabolism, oncology and rare diseases
- Number of people150+
Global Business Division and New Product Development Division (Headquarters)
- LocationSongpa-gu, Seoul, South Korea
- a field of studyClinical research, Regulatory affairs, In/out-licensing
- Number of people120+
Pharmaceutical Research Center
- LocationPaltan, Gyeonggi-do, South Korea
  Gwanggyo, Gyeonggi-do, South Korea
- a field of studyDeveloping combination drugs and new drugs formulation based on drug delivery system
- Number of people60+
Bioprocess Development Team (Pyeongtaek Site)
- LocationPyeongtaek, Gyeonggi-do, South Korea
- a field of studyManufacturing and development of recombinant protein products based on microbial fermentation and biochemical conjugation reaction processes
- Number of people50+
Hanmi Fine Chemical R&D Center
- LocationSihwa, Gyeonggi-do, South Korea
- a field of studyProcess development of APIs such as small molecules, peptides, PEGs, and mRNA raw materials
- Number of people50+
Beijing Hanmi R&D Center
- LocationBeijing, China
- a field of studyNew bispecific antibodies based on our proprietary PENTAMBODY platform technology
- Number of people150+